U.S. Markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
218.29-9.43 (-4.14%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close227.72
Bid210.03 x 1300
Ask227.00 x 900
Day's Range217.41 - 230.72
52 Week Range183.46 - 336.99
Avg. Volume131,374
Market Cap2.567B
Beta (5Y Monthly)1.41
PE Ratio (TTM)20.63
EPS (TTM)10.58
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & Yield5.68 (2.86%)
Ex-Dividend DateSep 20, 2021
1y Target Est363.33
  • Zacks

    Should Value Investors Pick Medifast (MED) Stock Now?

    Is Medifast (MED) a great pick from the value investor's perspective right now? Read on to know more.

  • Benzinga

    Notable Medifast Insider Makes $970K Buy

    Jeffrey Brown, Insider at Medifast (NYSE:MED), made a large insider buy on November 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Brown purchased 4,200 shares of Medifast at at prices ranging from $218.49 to $235.28. The total transaction amounted to $973,911. Brown now owns a total of 34,957 of Medifast worth, 8,002,188. Medifast shares are trading up 2.77% at $228.92 at the time of this writing on Thursda

  • Benzinga

    4 Stocks Insiders Are Buying

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. CommScope The Trade: Com